Erik Van Werkhoven

Erik Van Werkhoven

Johns Hopkins University - Baltimore / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 1431405
person_outline Erik Van Werkhoven's MOST POPULAR ARTICLES
1-) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...The lancet oncology 16 (6), 630-637, 201513352015
2-) Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trialL Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...Nature medicine 25 (6), 920-928, 20194652019
3-) Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSN Ooft, F Weeber, KK Dijkstra, CM McLean, S Kaing, E van Werkhoven, ...Science translational medicine 11 (513), eaay2574, 20194272019
4-) Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapyS Leijen, SA Burgers, P Baas, D Pluim, M Tibben, E van Werkhoven, ...Investigational new drugs 33, 201-214, 20154922015
5-) DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysisLM Henricks, CATC Lunenburg, FM de Man, D Meulendijks, ...The Lancet Oncology 19 (11), 1459-1467, 20183892018